Determining the appropriate retatrutide dosage is critically essential for achieving best outcomes . Initially, individuals typically commence with a low amount of approximately 2.4 mg, administered every week via under the skin . This preliminary dose is then incrementally raised every four periods, until a maximum amount of 10.8 mg, according to